arfill dermal filler
HA 24mg/ml, Lidocaine 0.3%, Superficial / Mid Dermis, 1.1ml, 27G
High Complex Viscosity / Easy Injection
Safe raw material which is controlled by the separated lines
Highest purified HA to guarantee duration and prevent swelling
Optimized viscoelasticity to lift up accurately
Technology to produce homogeneous molecular size to enable exquisite molding
No detection of remaining chemical catalyst through perfect cross-link process
Aseptic manufacturing environment to prevent side effects
Strict criteria less than 0.1 EU/ml endotoxin
pH and osmotic pressure as same as the human body to minimize the pain of injection
Ideal viscoelasticity shall lift up the tissue and make easy molding and maintain the natural beautiful shape.
Starfill dermal fillers are obtained using the “Zero Endotoxin and BDDE Entire Process” (ZEEP) technology, which guarantees minimized endotoxin and residual BDDE levels. The product has a high HA cross-linking degree, outstanding viscoelasticity, and cohesiveness parameter values. Low toxin and cross-linking agent levels ensure the high safety of the product while minimizing the risk of post-injection edema, allergic reactions, and other side effects. Uniform gel particle size contributes to the even distribution of the filler during injection and better aesthetic effect. 
The presence of lidocaine in the composition makes the procedure painless.
Other Starfill Dermal Fillers include:
StarFill Implant Plus Lidocaine (1 x 1.1ml)
StarFill Deep Plus Lidocaine (1 x 1.1ml)
Starfill dermal filler is manufactured by Jetema who produce Regenovue and EPTQ filler (Epitique)